T Cell Biomarkers in Autoimmunity for Target Discovery & Treatment Monitoring
Time: 10:00 am
day: Day One
Details:
- Use T-cell repertoire to determine HLA type for high-risk alleles
- Monitor-T cell response to immune modifying therapies as a biomarker of activity
- Map T-cell clones to self-antigens to identify disease targets and track antigenspecific response to therapy
